Target intelligence / Profile preview

MicroRNA 5191 (MIR5191)

Target
MIR5191
Molecular classification
Non-coding RNA, MicroRNA
01

Overview

MicroRNA 5191 (MIR5191) is a small, non-coding RNA molecule belonging to the microRNA family, which regulates gene expression by binding to complementary sequences on target messenger RNAs, resulting in translational repression or mRNA degradation[4][3]. MIR5191 is annotated in the human genome with the HGNC symbol MIR5191 and is expressed as part of the broad pool of circulating and tissue microRNAs. While large-scale machine learning studies on cancer classification have occasionally included MIR5191 in high-dimensional miRNA panels[1], there is currently no robust evidence linking MIR5191 to specific diseases, biological pathways, or druggable mechanisms. Like most members of the microRNA family, MIR5191 may contribute to biological processes such as cell proliferation, apoptosis, and differentiation, primarily through the fine-tuning of gene expression, but it is not a canonical therapeutic target[4][3][1].

Other names
hsa-mir-5191hsa-miR-5191MIR5191
02

Mechanism of action

Not applicable for drugs, as there are no drugs targeting this microRNA.

03

Biological functions

Regulation of gene expression (post-transcriptional silencing)Possible involvement in cell proliferation, apoptosis, and cellular differentiation (inferred from general microRNA biology, as no function specific to MIR5191 is highlighted in key reviews)
04

Disease associations

Other
05

Safety considerations

Not applicable, as there are no drugs or therapies specifically targeting MIR5191, so safety concerns are not defined.
06

Biomarkers

Although MIR5191 may be present in large miRNA panels analyzed for cancer or tissue classification[1], it is not currently recognized as a specific clinical biomarker for patient selection or therapeutic efficacy monitoring.

Beyond the preview

Go deeper on MicroRNA 5191 (MIR5191).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MicroRNA 5191 (MIR5191).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call